» Articles » PMID: 25164983

Participation in Society for People with a Rare Diagnosis

Overview
Publisher Elsevier
Date 2014 Aug 29
PMID 25164983
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many rare diagnoses are syndromes that have complex consequences with a significant impact on the individuals' everyday life. Adults with rare diagnoses are a growing group and knowledge about their needs is often scarce.

Objective: The objective was to investigate the experiences of adults living with different rare diagnoses, how they perceived their difficulties, needs and participation in everyday life, and to identify some common issues and problems.

Method: Individuals with four different diagnoses were interviewed in four focus groups: Artrogryposis Multiplex Congenita AMC (n = 9), Dysmelia (n = 11), 22q11 deletion syndrome (n = 10) and Klinefelter syndrome (n = 8). The interviews focused on the following topics; education, working life, daily routines, sleep, housing, health care and society support system contacts. The study was conducted as qualitative research using content analysis.

Results: The participants described their needs and perceived consequences from not having their everyday needs met. A major theme covers most of the participants' experiences: Complex and varying consequences of the condition have an impact on their participation in education, working and everyday life, mostly due to contextual barrier factors.

Conclusion: The interviewees are affected by different rare conditions. Despite these differences they face similar challenges, due to the low prevalence of their condition and the resulting lack of both knowledge and holistic perspective of service providers. To gather, disseminate and implement information about rare conditions in society is thus a very important task. It is equally important to improve the ways to transfer information and to promote cooperation between service providers.

Citing Articles

Translating patient needs into medical device development: co-design of a photoprotection visor for Xeroderma Pigmentosum using qualitative interviews.

Graham T, Sooriah S, Chang Y, Hashimdeen S, Meydan T, Grocott P Orphanet J Rare Dis. 2024; 19(1):64.

PMID: 38351060 PMC: 10865654. DOI: 10.1186/s13023-023-03002-y.


Non-pharmacological rehabilitation interventions for individuals with antiphospholipid syndrome: A scoping review.

Harper A, Chen Y, Tancer S, Rodgers K, Crumb A, Townsend W Lupus. 2023; 33(2):101-110.

PMID: 38113856 PMC: 11003253. DOI: 10.1177/09612033231223336.


Enhancing evidence-informed policymaking in medicine and healthcare: stakeholder involvement in the Commons Project for rare diseases in Japan.

Kogetsu A, Isono M, Aikyo T, Furuta J, Goto D, Hamakawa N Res Involv Engagem. 2023; 9(1):107.

PMID: 38031179 PMC: 10685685. DOI: 10.1186/s40900-023-00515-5.


Psychosocial impact at the time of a rare disease diagnosis.

Benito-Lozano J, Arias-Merino G, Gomez-Martinez M, Arconada-Lopez B, Ruiz-Garcia B, Posada de la Paz M PLoS One. 2023; 18(7):e0288875.

PMID: 37506095 PMC: 10381039. DOI: 10.1371/journal.pone.0288875.


'Struggling to participate in everyday life': emerging adults' experiences of living with long-term health challenges.

Rasalingam A, Brekke I, Stenberg U, Haaland-Overby M, Helseth S BMC Public Health. 2023; 23(1):1368.

PMID: 37460986 PMC: 10353226. DOI: 10.1186/s12889-023-16291-6.